APA (7th ed.) Citation

YC, H., JS, C. C., ML, C., HC, L., WT, C., SW, C., . . . CB, J. (2026). Preventive effects of Larazotide acetate (AT-1001) on non-alcoholic fatty liver diseases (NAFLD) in a mouse model. Pediatrics and neonatology, 67(1), 84. https://doi.org/10.1016/j.pedneo.2025.01.016

Chicago Style (17th ed.) Citation

YC, Huang, Chiang Chiau JS, Cheng ML, Lee HC, Chan WT, Chang SW, Chen YC, Yeung CY, and Jiang CB. "Preventive Effects of Larazotide Acetate (AT-1001) on Non-alcoholic Fatty Liver Diseases (NAFLD) in a Mouse Model." Pediatrics and Neonatology 67, no. 1 (2026): 84. https://doi.org/10.1016/j.pedneo.2025.01.016.

MLA (9th ed.) Citation

YC, Huang, et al. "Preventive Effects of Larazotide Acetate (AT-1001) on Non-alcoholic Fatty Liver Diseases (NAFLD) in a Mouse Model." Pediatrics and Neonatology, vol. 67, no. 1, 2026, p. 84, https://doi.org/10.1016/j.pedneo.2025.01.016.